{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:04:30Z","timestamp":1753891470440,"version":"3.41.2"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Guillain\u2013Barr\u00e9 syndrome (GBS) is a potentially fatal, immune-mediated disease of the peripheral nervous system that is usually triggered by infection. Only a small number of cases of GBS associated with COVID-19 infection have been published. We report here five patients with GBS admitted to the Neurology, Psychiatry, and Neurosurgery Hospital, Assiut University\/Egypt from July 1 to November 20, 2020. Three of the five patients were positive for SARS-CoV-2 following polymerase chain reaction (PCR) of nasopharyngeal swabs on day of admission and another one had a high level of IgM and IgG; all had bilateral ground-glass opacities with consolidation on CT chest scan (GGO) and lymphopenia. All patients presented with two or more of the following: fever, cough, malaise, vomiting, and diarrhea with variable duration. However, there were some peculiarities in the clinical presentation. First, there were only 3 to 14 days between the onset of COVID-19 symptoms and the first symptoms of GBS, which developed into flaccid areflexic quadriplegia with glove and stocking hypoesthesia. The second peculiarity was that three of the cases had cranial nerve involvement, suggesting that there may be a high incidence of cranial involvement in SARS-CoV-2-associated GBS. Other peculiarities occurred. Case 2 presented with a cerebellar hemorrhage before symptoms of COVID-19 and had a cardiac attack with elevated cardiac enzymes following onset of GBS symptoms. Case 5 was also unusual in that the onset began with bilateral facial palsy, which preceded the sensory and motor manifestations of GBS (descending course). Neurophysiological studies showed evidence of sensorimotor demyelinating polyradiculoneuropathy, suggesting acute inflammatory polyneuropathy (AIDP) in all patients. Three patients received plasmapheresis. All of them had either full recovery or partial recovery. Possible pathophysiological links between GBS and COVID-19 are discussed.<\/jats:p>","DOI":"10.3389\/fneur.2021.678136","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T04:56:25Z","timestamp":1624337785000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Case Report: Guillain\u2013Barr\u00e9 Syndrome Associated With COVID-19"],"prefix":"10.3389","volume":"12","author":[{"given":"Eman M.","family":"Khedr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Shoyb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled O.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed A.","family":"Karim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Saber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e00771","DOI":"10.1016\/j.idcr.2020.e00771","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection","volume":"20","author":"Virani","year":"2020","journal-title":"IDCases."},{"key":"B2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: causality or coincidence?","volume":"19","author":"Zhao","year":"2020","journal-title":"Lancet Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jhin.2016.10.008","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications","volume":"95","author":"Kim","year":"2017","journal-title":"J Hospital Infect."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Nobuhiro","year":"2012","journal-title":"N Engl J Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria","volume":"137","author":"Fokke","year":"2014","journal-title":"Brain."},{"key":"B7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/jns.12419","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: a systematic review and individual participant data meta-analysis","volume":"25","author":"Hasan","year":"2020","journal-title":"J Peripher Nerv Syst."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/fmaa044","article-title":"Guillain\u2013Barr\u00e9 syndrome associated with SARS-CoV-2 infection in a pediatric patient","author":"Frank","year":"2020","journal-title":"J Trop Pediatr."},{"key":"B9","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/jpids\/piaa086","article-title":"Guillain-Barre syndrome associated with SARS-CoV-2 detection and a COVID-19 infection in a child","volume":"9","author":"Khalifa","year":"2020","journal-title":"J Pediatr Infect Dis Soc."},{"key":"B10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/NRL.0000000000000291","article-title":"Guillain-Barr\u00e9 syndrome as a neurological complication of novel COVID-19 infection: a case report and review of the literature","volume":"25","author":"Paybast","year":"2020","journal-title":"Neurologist."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-020-10124-x","article-title":"Guillain\u2013Barr\u00e9 syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases","volume":"268","author":"Abu-Rumeileh","year":"2020","journal-title":"J Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s42399-020-00646-w","article-title":"COVID-19-Associated Guillain-Barre syndrome: atypical para-infectious profile, symptom overlap, and increased risk of severe neurological complications","author":"Kajumba","year":"2020","journal-title":"SN Compr Clin Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1093\/brain\/awy232","article-title":"Regional variation of Guillain-Barr\u00e9 syndrome","volume":"141","author":"Doets","year":"2018","journal-title":"Brain."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1056\/NEJMoa1605564","article-title":"Guillain\u2013Barr\u00e9 syndrome associated with Zika virus infection in Colombia","volume":"375","author":"Parra","year":"2016","journal-title":"N Engl J Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-barre syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.13.20130062","article-title":"Guillain Barr e syndrome in COVID-19: a scoping review","author":"Ahmad","year":"2020","journal-title":"medRxiv."},{"key":"B17","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1021\/acschemneuro.0c00122","article-title":"Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host\u2013virus interaction, and proposed neurotropic mechanisms","volume":"11","author":"Baig","year":"2020","journal-title":"ACS Chem Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"117263","DOI":"10.1016\/j.jns.2020.117263","article-title":"Guillain Barr\u00e9 Syndrome and its variants as a manifestation of COVID-19: a systemic review of case report and case series","volume":"420","author":"Sriwastava","year":"2020","journal-title":"J Neurol Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.33588\/rn.7009.2020179","article-title":"Neurological complications of coronavirus and COVID-19","volume":"70","author":"Carod-Artal","year":"2020","journal-title":"Revista de Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell."},{"key":"B21","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10072-020-04553-9","article-title":"Is Guillain-Barr\u00e8 syndrome triggered by SARS-CoV-2? Case report and literature review","volume":"42","author":"Agosti","year":"2021","journal-title":"Neurol Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jocn.2020.05.016","article-title":"Facial diplegia, a possible atypical variant of Guillain-Barr\u00e9 Syndrome as a rare neurological complication of SARS-CoV-2","volume":"77","author":"Caama\u00f1o","year":"2020","journal-title":"J Clin Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1017\/cjn.2020.106","article-title":"Guillain-Barr\u00e9 syndrome with facial diplegia related to SARS-CoV-2 infection","volume":"47","author":"Chan","year":"2020","journal-title":"Can J Neurol Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1365-2249.2009.03996.x","article-title":"Intravenous immunoglobulin preparations have no direct effect on B cell proliferation and immunoglobulin production","volume":"158","author":"Heidt","year":"2009","journal-title":"Clin Exp Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-021-06031-9","article-title":"IgG and IgM antibody formation to spike and nucleocapsid proteins in COVID-19 characterized by multiplex immunoblot assays","volume":"21","author":"Shah","year":"2021","journal-title":"BMC Infect Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1136\/jnnp-2016-314862","article-title":"Treatment dilemmas in Guillain-Barr\u00e9 syndrome","volume":"88","author":"Verboon","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B27","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain\u2013Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat Rev Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.clinph.2012.01.025","article-title":"Electrodiagnostic criteria for Guillain\u2013Barr\u00e9 syndrome: a critical revision and the need for an update","volume":"123","author":"Uncini","year":"2012","journal-title":"Clin Neurophysiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"CD001798","DOI":"10.1002\/14651858.CD001798.pub2","article-title":"Plasma exchange for Guillain-Barr\u00e9 syndrome","volume":"2","author":"Raphael","year":"2012","journal-title":"Cochrane Database of Syst Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/mus.27024","article-title":"COVID-19\u2013associated Guillain-Barr\u00e9 syndrome: the early pandemic experience","volume":"62","author":"Caress","year":"2020","journal-title":"Muscle Nerve."},{"key":"B31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.17161\/rrnmf.v1i3.13816","article-title":"Neuromuscular complications in COVID-19: a review of the literature","volume":"1","author":"Pike-Lee","year":"2020","journal-title":"RRNMF Neuromuscul J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain\u2013Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"Van Den Berg","year":"2014","journal-title":"Nat Rev Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/brain\/awaa433","article-title":"Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barr\u00e9 syndrome","volume":"144","author":"Keddie","year":"2021","journal-title":"Brain."},{"key":"B34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3390\/life11020167","article-title":"Post-infectious Guillain\u2013Barr\u00e9 syndrome related to SARS-COV-2 infection: a systematic review","volume":"11","author":"Sansone","year":"2021","journal-title":"Life."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.678136\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T04:56:27Z","timestamp":1624337787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.678136\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":34,"alternative-id":["10.3389\/fneur.2021.678136"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.678136","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2021,6,22]]},"article-number":"678136"}}